We have moved! In the course of our general expansion strategy, the company has decided to build a new, state of the art office building, in order to fulfil future needs. Now, after almost 12 months of intense planning- and construction work, we are very proud to announce the completion of this challenging project. With almost 1,000 m² of bright, modern offices, combined with functional storage- and packing space, we are confident, we have established a good environment for our employees in order to ensure high quality services for our valued customers.
In light of this move, our address, as well as phone numbers have changed. Our new address can be found here and our new contact information (our email addresses stay the same) can be found here (phone numbers will be updated soon).
NUKEM Isotopes GmbH and NUKEM Isotopes Imaging GmbH have successfully completed its re-certification audits, performed by BSI Group Deutschland GmbH, for the new ISO 9001:2015 quality management standard for NUKEM’s activities in trading isotopes and trading isotops for medical purposes.
As supporter for supplying high enriched Oxygen-17 (70at%) gas, we are proud to announce that the manuscript “Reproducibility of CMRO2 Determination using Dynamic 17O MRI”, submitted by the German Cancer Research Center (DKFZ) and the University of Erlangen, was accepted for publication by the journal Magnetic Resonance in Medicine. The manuscript will probably be online by end October 2017.
NUKEM Isotopes GmbH successfully completed the REACH-Registration for Li-7OH*H2O. This Registration entitles us to import more than 1t/a of Li-7OH*H2O into the European Union also after May 31st, 2018. Thus, we are perfectly prepared to cover the future Li-7 demand of our customers.
NUKEM Isotopes Imaging GmbH successfully participated at this year’s ISMRM in Honolulu. We thank all visitors for stopping by at our booth.
In cooperation with the University of Freiburg, NUKEM Isotopes Imaging GmbH carried out experiments with enriched Oxygen-17 in the form of D-Glucose. Now we are pleased to announce that the University of Freiburg got the manuscript accepted by the journal NMR in Biomedicine.
In cooperation with the University of Heidelberg and the Florida State University, NUKEM Isotopes Imaging GmbH carried out experiments to verify a new technique for detecting brain tumors with enriched Oxygen-17 in the form of D-Glucose.
NUKEM Isotopes GmbH and NUKEM Isotopes Imaging GmbH have successfully completed its surveillance audit, performed by BSI Group Deutschland GmbH. This audit has proven both companies operates a Quality Management System which complies with the requirements of ISO 9001:2008 for trading isotopes and trading isotops for medical purposes.
NUKEM Isotopes GmbH and NUKEM Isotopes Imaging GmbH launched their new website.
NUKEM Isotopes GmbH has successfully completed its re-qualification audit, performed by NUPIC member group. This audit has proven NUKEM’s management system in accordance to 10CFR50 App.B and 10CFR21. NUPIC audit team consists of professional auditior from Ameren UE, Vattenfall Ringhals Kärnkraftverk and Arizona Public Service Electric Company (APS).
NUKEM Isotopes GmbH decides to participate in Polarean, Inc. a pioneer in hyperpolarized gas technology. This stragegic decision enables NUKEM Isotopes to supply enriched Xenon-129 for lung imaging in MRT.
NUKEM Isotopes GmbH establishes reliable partnerships with gas manufacturers for the production of highly pure noble gases.